Tus kws kho mob
QP24-25 Commercial Pharmacy Benefit Exclusion for Octreotide Kit, Sandostatin® Kit LAR, and Signifor® LAR injection
Hnub Tim pib siv tau lub khoos kas: Lub Peb Hlis Ntuj Tim 12, 2025
Tshawb Nrhiav
Nthuav pom cov txiaj ntsig tshwm sim 991 - 1000 ntawm 4139
Tus kws kho mob
QP23-25 Commercial Pharmacy Benefit Exclusion for Kebilidi™, Niktimvo™, Steqeyma® and Yesintek™
Hnub Tim pib siv tau lub khoos kas: Lub Peb Hlis Ntuj Tim 12, 2025
Tus kws kho mob
QP22-25 Provider Press: Q1 2025
Hnub Tim pib siv tau lub khoos kas: Lub Peb Hlis Ntuj Tim 12, 2025
Tus kws kho mob
QP21-25 Appropriate Use of Modifier -25
Hnub Tim pib siv tau lub khoos kas: Lub Peb Hlis Ntuj Tim 12, 2025
Tus kws kho mob
P39-25 New Medical and Behavioral Health Policy Management Updates, Effective September 1, 2025
Hnub Tim pib siv tau lub khoos kas: Lub Xya Hli Ntuj Tim 01, 2025